| Yancheng Langde Chemical & Pharmaceutical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (515) 8835-9955 +86 13705103058 | |||
![]() |
langdechem@163.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2006 | ||||
| chemBlink standard supplier since 2006 | ||||
| Capot Chemical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (571) 8558-6718 +86 13336195806 | |||
![]() |
capotchem@gmail.com sales@capotchem.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2006 | ||||
| Nanjing Finetech Chemical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (25) 5207-8417 +86 17714198479 | |||
![]() |
sales@fine-chemtech.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2007 | ||||
| chemBlink standard supplier since 2007 | ||||
| Simagchem Corporation | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 13806087780 | |||
![]() |
sale@simagchem.com | |||
| Chemical manufacturer since 2002 | ||||
| chemBlink standard supplier since 2008 | ||||
| BrightGene Bio-medical Technology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (512) 6255-1801 6255-1767 +86 13812696362 | |||
![]() |
kevinwan@bright-gene.com kevinwan0203@gmail.com | |||
![]() |
Skype Chat | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2001 | ||||
| chemBlink standard supplier since 2009 | ||||
| Quzhou Synpartner Pharmaceutical Technology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (570) 385-6346 +86 18605706399 | |||
![]() |
sales@synpartner.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2009 | ||||
| Taicang Qianjing Chemical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (512) 5364-5646 | |||
![]() |
sales@qjchem.com tcqxh@hotmail.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2009 | ||||
| Sinocompound Catalysts Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (512) 6721-6630 | |||
![]() |
sales@sinocompound.com | |||
| Chemical manufacturer since 2008 | ||||
| chemBlink standard supplier since 2010 | ||||
| Classification | Organic raw materials >> Amino compound >> Sulfonic acid amino compound |
|---|---|
| Name | Cyclen |
| Synonyms | 1,4,7,10-Tetraazacyclododecane |
| Molecular Structure | ![]() |
| Molecular Formula | C8H20N4 |
| Molecular Weight | 172.27 |
| CAS Registry Number | 294-90-6 |
| EC Number | 425-450-9 |
| SMILES | C1CNCCNCCNCCN1 |
| Solubility | 1e+006 mg/L (25 ºC water) |
|---|---|
| Density | 0.9±0.1 g/cm3, Calc.* |
| Index of Refraction | 1.424, Calc.* |
| Melting point | 127.01 ºC |
| Boiling Point | 283.8±8.0 ºC (760 mmHg), Calc.*, 330.67 ºC |
| Flash Point | 129.5±13.5 ºC, Calc.* |
| * | Calculated using Advanced Chemistry Development (ACD/Labs) Software. |
| Hazard Symbols |
| ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Statements | H302-H312-H314-H400-H410 Details | ||||||||||||||||||||||||||||||||||||||||
| Precautionary Statements | P260-P264-P270-P273-P280-P301+P317-P301+P330+P331-P302+P352-P302+P361+P354-P304+P340-P305+P354+P338-P316-P317-P321-P330-P362+P364-P363-P391-P405-P501 Details | ||||||||||||||||||||||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||||||||||||||||||||||
|
Cyclen, short for 1,4,7,10-tetraazacyclododecane, stands as a remarkable discovery in the realm of coordination chemistry. It was first synthesized in the mid-20th century through systematic chemical modifications aimed at creating macrocyclic compounds with unique properties. Cyclen's discovery marked a significant advancement in the field of metal coordination chemistry, as its structure allows for the formation of stable complexes with metal ions. Cyclen and its derivatives are widely utilized in metal chelation therapy for the treatment of heavy metal poisoning and metal ion imbalances. Their ability to selectively bind to metal ions such as copper, zinc, and iron helps remove excess metals from the body, preventing their toxic effects and restoring physiological metal homeostasis. Cyclen derivatives, known as macrocyclic chelators, are employed as contrast agents in magnetic resonance imaging (MRI). By chelating paramagnetic metal ions such as gadolinium, Cyclen enhances the contrast between different tissues and organs, improving the visualization of anatomical structures and pathological changes in diagnostic imaging. Cyclen-based ligands serve as catalysts in various chemical reactions, including asymmetric synthesis, organic transformations, and polymerization processes. Their coordination properties and structural rigidity enable efficient catalytic activation of substrates, facilitating the synthesis of complex molecules with high yields and selectivity. Cyclen and its derivatives play a pivotal role in supramolecular chemistry, where they serve as building blocks for the construction of molecular cages, hosts, and receptors. Their ability to form stable complexes with guest molecules enables the design of functional materials with tailored properties for applications in drug delivery, sensing, and molecular recognition. Cyclen-based compounds are valuable tools in biomedical research for studying metal ion metabolism, protein structure, and enzyme function. They are utilized as probes and modulators of metal-dependent biological processes. Cyclen scaffolds are integrated into the design of pharmaceutical agents for enhancing drug stability, solubility, and targeting. Cyclen-based drugs exhibit improved pharmacokinetic properties and reduced off-target effects, making them attractive candidates for the development of novel therapeutic agents for cancer, infectious diseases, and neurological disorders. References 2023. Synthesis of tris- and pentakis(tetra-armed cyclen) and their complexing properties towards silver(I) ions, _Journal of Inclusion Phenomena and Macrocyclic Chemistry_, 103(5-6) DOI: https://doi.org/10.1007/s10847-023-01189-y 2021, Synthesis of DOTA-pyridine chelates for 64Cu coordination and radiolabeling of αMSH peptide, _EJNMMI Radiopharmacy and Chemistry_, 6(1) DOI: https://doi.org/10.1186/s41181-020-00119-4 2012, Biodegradable cyclen-based linear and cross-linked polymers as non-viral gene vectors, _Bioorganic & Medicinal Chemistry_, 20(4) DOI: https://doi.org/10.1016/j.bmc.2012.01.016 |
| Market Analysis Reports |
| List of Reports Available for Cyclen |